During an official working visit to the United Kingdom, a leadership delegation from Vietnam’s Ministry of Health conducted a site visit and held high-level talks at AstraZeneca’s Discovery Centre (DISC) in Cambridge. The meeting focused on innovative solutions to reinforce health systems and the integration of technology in medical treatment.
Key discussion topics included:
-
Technological Innovation: Both parties exchanged roadmaps for applying Artificial Intelligence (AI) and digital transformation in pharmaceuticals, while emphasizing the protection of intellectual property rights for new medical inventions.
-
Sustainable Healthcare Access: AstraZeneca proposed novel financial mechanisms to enhance patient access to specialized medications and cutting-edge therapeutic solutions.
-
Non-Communicable Disease (NCD) Management: Strengthening the role of screening and early detection as a cornerstone for effectively managing chronic conditions, including cancer, cardiovascular diseases, kidney diseases, and respiratory issues.
The Ministry of Health representatives acknowledged the corporation’s practical contributions to community projects in Vietnam, such as respiratory health initiatives, cardio-metabolic care, and disease prevention programs for youth. Looking ahead, both sides aim to further promote scientific research, high-level human resource training, and the transfer of modern medical technologies.